Grassi Investment Management Exact Sciences Corp Transaction History

Grassi Investment Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 13, 2020	SELL	$72.92 - $102.01 $1.6 Million - $2.23 Million	-21,900 Closed	0 $0
Q2 2020 Jul 15, 2020	SELL	$55.75 - $92.75 $104,531 - $173,906	-1,875 Reduced 7.89%	21,900 $1.9 Million
Q1 2020 Apr 08, 2020	BUY	$37.9 - $104.44 $176,235 - $485,646	4,650 Added 24.31%	23,775 $1.38 Million
Q4 2019 Jan 10, 2020	BUY	$77.66 - $99.74 $974,633 - $1.25 Million	12,550 Added 190.87%	19,125 $1.77 Million
Q3 2019 Oct 04, 2019	BUY	$90.37 - $122.49 $210,110 - $284,789	2,325 Added 54.71%	6,575 $594,000
Q2 2019 Jul 10, 2019	BUY	$89.51 - $118.04 $380,417 - $501,670	4,250 New	4,250 $502,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Grassi Investment Management, based on Form 13F filings with the SEC.

Stay updated on Grassi Investment Management with notifications on news.